EpiTherapeutics is a biopharmaceutical company developing novel innovative cancer drugs based on the world leading research in the field of epigenetics. EpiTherapeutics' development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. EpiTherapeutics is based in Denmark.
Location: Denmark, Capital Region of Denmark, Copenhagen
Member count: 5001-10000
Founded date: 2008
Investors 1
| Date | Name | Website |
| 08.11.2022 | M Ventures | m-ventures... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 29.01.2011 | EpiTherape... | EpiTherapeutics, a Copenhagen,... | Denmark v... | - | finsmes.co... |